Latest News
Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031
GlobeNewswire - Wed Sep 4, 7:30AM CDT
GlobeNewswire
Wed Sep 4, 7:30AM CDT
Inovio Pharmaceuticals (INO) Q2 2024 Earnings Call Transcript
Motley Fool - Fri Aug 9, 1:30AM CDT
Motley Fool
Fri Aug 9, 1:30AM CDT
INO earnings call for the period ending June 30, 2024.
5 Analyst-Approved Stocks Set to Join the Russell Microcap Index
Barchart - Thu Jun 6, 7:00AM CDT
Barchart
Thu Jun 6, 7:00AM CDT
As a part of the annual Russell index rebalancing, here are five stocks set to join the Russell Microcap Index this year, which analysts have tagged with consensus โbuyโ ratings.
Better Buy: Inovio Pharmaceuticals vs. Novavax
Motley Fool - Wed May 22, 8:45AM CDT
Motley Fool
Wed May 22, 8:45AM CDT
Both biotechs have been struggling for a while, but there might be some hope for them.
Inovio Pharmaceuticals (INO) Q1 2024 Earnings Call Transcript
Motley Fool - Mon May 13, 8:45PM CDT
Motley Fool
Mon May 13, 8:45PM CDT
INO earnings call for the period ending March 31, 2024.
This Under-the-Radar Stock Is Up by 96% This Year: Time to Buy?
Motley Fool - Sun May 5, 7:54AM CDT
Motley Fool
Sun May 5, 7:54AM CDT
Can the biotech succeed after a string of failures?
Inovio Pharmaceuticals (INO) Q4 2023 Earnings Call Transcript
Motley Fool - Wed Mar 6, 10:30PM CST
Motley Fool
Wed Mar 6, 10:30PM CST
INO earnings call for the period ending December 31, 2023.
Inovio Pharmaceuticals (INO) Q3 2023 Earnings Call Transcript
Motley Fool - Thu Nov 9, 2023
Motley Fool
Thu Nov 9, 2023
INO earnings call for the period ending September 30, 2023.
INOVIO Announces U.S. FDA Breakthrough Therapy Designation Granted for INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis
PR Newswire - Thu Sep 7, 2023
PR Newswire
Thu Sep 7, 2023
/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...
Inovio Pharmaceuticals (INO) Q2 2023 Earnings Call Transcript
Motley Fool - Wed Aug 9, 2023
Motley Fool
Wed Aug 9, 2023
INO earnings call for the period ending June 30, 2023.
INOVIO Announces Second Quarter 2023 Financial Results and Provides Strategic Update
PR Newswire - Wed Aug 9, 2023
PR Newswire
Wed Aug 9, 2023
Preparing to initiate pivotal Phase 3 trial of INO-3107 in adult RRP patients in first quarter of 2024; INO-3107 received Orphan Drug Designation from European...
INOVIO Reports Inducement Grants Under Inducement Plan
PR Newswire - Fri Aug 4, 2023
PR Newswire
Fri Aug 4, 2023
/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...
INOVIO to Report Second Quarter 2023 Financial Results on August 9, 2023
PR Newswire - Wed Jul 26, 2023
PR Newswire
Wed Jul 26, 2023
/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...
INOVIO Announces Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions
GlobeNewswire - Fri Jun 23, 2023
GlobeNewswire
Fri Jun 23, 2023
INOVIO to Present at the 2023 Jefferies Healthcare Conference
PR Newswire - Thu May 25, 2023
PR Newswire
Thu May 25, 2023
/PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...
INOVIO Announces Orphan Drug Designation for INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis from the European Commission
PR Newswire - Tue May 23, 2023
PR Newswire
Tue May 23, 2023
/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...
Inovio Pharmaceuticals (INO) Q1 2023 Earnings Call Transcript
Motley Fool - Thu May 11, 2023
Motley Fool
Thu May 11, 2023
INO earnings call for the period ending March 31, 2023.
INOVIO Reports First Quarter 2023 Financial Results and Operational Highlights
PR Newswire - Wed May 10, 2023
PR Newswire
Wed May 10, 2023
Announced additional positive data from Phase 1/2 trial for INO-3107 in recurrent respiratory papillomatosis patients Second cohort of trial showed 10 of the...
INOVIO to Present at the 2023 RBC Capital Markets Global Healthcare Conference
PR Newswire - Fri May 5, 2023
PR Newswire
Fri May 5, 2023
/PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...
INOVIO to Report First Quarter 2023 Financial Results on May 10, 2023
PR Newswire - Fri Apr 28, 2023
PR Newswire
Fri Apr 28, 2023
/PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...
These 3 Nasdaq Stocks Are on Fire Today: Here's Why
Motley Fool - Mon Apr 17, 2023
Motley Fool
Mon Apr 17, 2023
A high-dollar buyout is lighting a fire underneath these three Nasdaq stocks today.
Why Inovio Pharmaceuticals' Shares Jumped on Thursday
Motley Fool - Thu Apr 13, 2023
Motley Fool
Thu Apr 13, 2023
The company will present an abstract for its Ebola vaccine booster this month.
INOVIO Announces Acceptance of Abstract for Oral Presentation on INO-4201 as an Ebola Booster for rVSV-ZEBOV (Erveboยฎ) at ECCMID 2023
PR Newswire - Wed Apr 12, 2023
PR Newswire
Wed Apr 12, 2023
/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...
Why Shares of Inovio Pharmaceuticals Were Down Tuesday
Motley Fool - Tue Apr 4, 2023
Motley Fool
Tue Apr 4, 2023
The biotech stock, still reeling from a failed clinical trial, hit a 52-week low.
INOVIO Reports Inducement Grant Under Inducement Plan
PR Newswire - Mon Apr 3, 2023
PR Newswire
Mon Apr 3, 2023
/PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...